Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
79 studies found for:    Leiomyoma: Clinical Trials
Show Display Options
Rank Status Study
21 Terminated Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids
Condition: Leiomyoma
Interventions: Dietary Supplement: EGCG ( Green Tea extract);   Dietary Supplement: Brown rice pills
22 Terminated
Has Results
Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
Conditions: Uterine Fibroids;   Anemia
Interventions: Drug: Proellex 25 mg;   Drug: Proellex 50 mg;   Drug: Placebo
23 Terminated
Has Results
Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex 25 mg;   Drug: Proellex 50 mg
24 Completed Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial
Condition: Blood Loss, Surgical
Intervention: Drug: Vasopressin
25 Unknown  Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy
Conditions: Uterine Myoma;   Uterine Adenomyosis
Interventions: Procedure: Single incision Laparoscopic hysterectomy;   Procedure: Conventional laparoscopic hysterectomy
26 Unknown  Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution
Conditions: Menorrhagia;   Dysfunctional Uterine Bleeding;   Leiomyoma;   Pelvic Pain;   Endometriosis
Interventions: Procedure: Conventional Laparoscopic Hysterectomy (LH);   Procedure: Robot Assisted Hysterectomy
27 Active, not recruiting Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Procedure: UAE;   Procedure: HIFU
28 Active, not recruiting Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions
Conditions: Uterine Fibroids;   Myomas
Interventions: Procedure: Global Fibroid Ablation;   Procedure: Myomectomy
29 Active, not recruiting Biologic Predictors of Leiomyoma Treatment Outcomes
Conditions: Uterine Leiomyomas;   Fibroids;   Uterine Fibroids;   Myomas
Interventions: Genetic: DNA analysis;   Other: Hormonal analysis
30 Unknown  Laparoscopic Occlusion of Uterine Vessels Compared to Uterine Fibroid Embolization for Treatment of Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Procedure: Laparoscopic bilateral occlusion of uterine artery;   Procedure: Radiological embolization (UFE)
31 Completed Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
Conditions: Uterine Leiomyoma;   Fibroids
Intervention: Drug: Pirfenidone
32 Unknown  Clinical Test of the MRgHIFU System on Uterine Fibroids
Condition: Uterine Fibroids
Intervention: Device: MRgHIFU system
33 Completed Randomized Controlled Trial (RCT)Comparing GYNAECARE MORCELLEX Versus ROTOCUT GI Tissue Morcellators
Condition: Uterine Myomas
Interventions: Procedure: Laparoscopic myomectomy and supracervical hysterectomy with GYNECARE MORCELLEX;   Procedure: Laparoscopic myomectomy and supracervical hysterectomy with ROTOCUT G1
34 Recruiting Surgical Success After Laparoscopic vs Abdominal Hysterectomy
Conditions: Metrorrhagia;   Menorrhagia;   Leiomyoma;   Adenomyosis;   Pelvic Pain;   Endometriosis;   Pelvic Inflammatory Disease
Interventions: Procedure: Laparoscopic hysterectomy;   Procedure: Abdominal hysterectomy
35 Withdrawn Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms
Condition: Uterine Fibroids
Intervention: Drug: Proellex
36 Recruiting Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy
Condition: Fibroids
Interventions: Drug: GnRHa;   Drug: Ulipristal
37 Recruiting Misoprostol for Reduction of Blood Loss During Fibroid Surgery
Condition: Fibroids
Interventions: Drug: Misoprostol;   Drug: Placebo
38 Unknown  Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma
Condition: Uterine Leiomyoma
Intervention: Drug: ascorbic acid
39 Enrolling by invitation An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Conditions: Uterine Fibroids;   Heavy Menstrual Bleeding
Interventions: Drug: Elagolix;   Drug: Estradiol/Norethindrone Acetate
40 Unknown  Hysteroscopic Monopolar and Bipolar Resection
Conditions: Menorrhagia;   Fibroid;   Polyps
Intervention: Procedure: Hysteroscopic resection of fibroids, polyps and endometrium.

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years